The cutoffs we identified, above which a CD34− HLA-DR− (double-negative) constellation suggests an unlikely diagnosis of “APL-like” NPM1m AML (favoring APL) are presented in the Results section. The gene discussed is CD34; the disease is acute myeloid leukemia.